Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $26.60, but opened at $31.00. Anbio Biotechnology shares last traded at $26.4570, with a volume of 165 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, April 1st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Anbio Biotechnology presently has a consensus rating of “Sell”.

Anbio Biotechnology Stock Down 1.0%

The firm has a 50 day moving average price of $25.19.

Anbio Biotechnology (NASDAQ:NNNN) last released its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.